medigraphic.com

2015, Number S3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (S3)

Incidence of adverse events associated to the use of peripheral venous catheters

Buenfil-Vargas MA, Espinosa-Vital GJ, Rodriguez-Sing R, Miranda-Novales MG

Language: Spanish
References: 24
Page: 310-315
PDF size: 277.08 Kb.


ABSTRACT

Background: surveillance of adverse events associated to the use of peripheral short venous catheters is an indicator of quality of service. The objective of the study was to report the incidence and risk factors associated to adverse events in peripheral short venous catheters.
Methods: Prospective cohort study. All patients with a peripheral short venous catheter for › 48 hours were included. The outcome variables were dysfunction, chemical phlebitis and bacterial phlebitis. The data registered were age, sex, underlying diseases, nutritional status, site of placement, skin condition, administered intravenous fluids, and catheter dressing. Regarding statistical analysis, incidence rate for each adverse event was calculated per 100 catheters and per 1000 catheter-days. Univariate and multivariate analysis of risk factors were performed.
Results: 410 catheters were analyzed. Median of short venous catheter use was of three days. There was no evidence of infectious complications: 47 (11.4 %) presented chemical phlebitis and 231 (56.3 %) mechanical malfunction; the incidence rate was 35.6 and 175 per 1000 catheter-days, respectively. In the multivariate analysis, the risk factors associated to chemical phlebitis were skin lesions (p = 0.001, RR 3.479), and additional dressing use (p = 0.007, RR 4.025); for mechanical malfunction the only risk factor was the administration of intravenous chemotherapy (p = 0.026, RR 4.293).
Conclusions: The malfunction incidence rate was high; in consequence, the catheter was removed before 96 hours of use. This could explain the absence of infectious complications.


REFERENCES

  1. Pujol M, Hornero A, Saballs M, Argerich MJ, Verdaguer R, Cisnal M, et al. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. J Hosp Infect. 2007;67(1):22-9.

  2. Castro-Hernández GO, Figueroa-García S, Leo-Méndez V. Experiencia en catéteres venosos centrales y periféricos en el centro estatal de cancerología, Veracruz, México, 2006-2009. Rev Med Universidad Veracruzana[Internet]. Enero-Junio; 2010: 11-16.

  3. Capdevila JA. El catéter periférico: el gran olvidado de la infección nosocomial. Rev Esp Quimioter. 2013;26(1):1-5.Texto libre http://seq.es/seq/0214- 3429/26/1/capdevila.pdf

  4. Hadaway L. Short peripheral intravenous catheters and infections. J Infus Nurs. 2012;35(4):230-40.

  5. Trejo y Pérez JA, Cabrera GR, Villasis KM, Padilla BG, Fajardo GA. Factores de riesgo para el desarrollo de flebitis bacteriana asociada a venoclisis en niños. Bol Med Hosp Infant Méx. 1994; 51(12):753-8.

  6. Guzmán RJ, Vélasquez JL, Núñez BR, Mota-Hernández F, Saiz-Calderón M, Briones-Rosales S. Complicaciones de las venoclisis en niños. Bol Med Hosp Infant Mex.1986; 43(4): 211-8.

  7. Ferreira-Machado A, Goncalves-Pedreira MLG, Noda-Chaud M. Eventos adversos relacionados al uso de catéteres intravenosos periféricos en niños según los tipos curativos. Rev Latino-am Enfermagem[Internet]. 2008;16(3). Disponible en: http://www.scielo.br/pdf/rlae/v16n3/es_05.pdf

  8. Consejo de Salubridad. l Guía de práctica clínica. Prevención, diagnóstico y tratamiento de las infecciones relacionadas a líneas vasculares[Internet]. México: Consejo de Salubridad; 2013.

  9. Tomford JW, Hershey C, McLaren C, Porter D, Cohen D. Intravenous therapy team and peripheral venous catheter associated complication. Arch Intern Med. 1984;144(6):1191-4.

  10. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections, Clin Infect Dis. 2011;52(9):e162-93.Texto libre http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC3106269/

  11. Rickard CM, Webster J, Wallis MC, Marsh N, Mc- Grail MR, French V, et al. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised control equivalence trial. Lancet. 2012;380(9847): 1066-74.

  12. Grüne F, Schrappe M, Basten J, Wenchel HM, Tual E, Stützer H; Cologne Quality Control Network. Phlebitis rate and time kinetics of short peripheral intravenous catheters. Infection. 2004;32(1);30-2.

  13. Mestre G, Berbel C, Tortajada P, Alarcia M, Coca R, Fernández MM, et al. Succesful multifaceted intervention aimed to reduce short peripheral venous catheter related adverse events: a quasi experimental cohort study. Am J Infect Control. 2013;41(6):520-6.

  14. Espinosa-Martinez D, Maldonado-Ramírez NE. Mantenimiento de los accesos vasculares en la UCI. Rev Asoc Mex Med Crit y Ter Int. 2008;22(4):236-40. Texto libre http://www.medigraphic.com/pdfs/medcri/ ti-2008/ti084f.pdf

  15. Bellido-Vallejo JC, Carrascosa-García MI, García- Fernandez FP, Tortosa-Ruiz MP, Mateos-Salido MJ, Delmoral-Jiménez J et al. Guía de cuidados en accesos venosos periféricos y centrales de inserción periférica. Evidentia[Internet]. 2006;3(9). Disponible en: http://www.index-f.com/evidentia/n9/guia-avp.pdf

  16. Ferrete-Morales C, Vázquez-Pérez MA, Sánchez- Berna M, Gilabert-Cerro I, Corzo-Delgado JE, Pineda- Vergara JA, et al. Incidencia de flebitis secundaria por catéter venoso de acceso periférico e impacto de un protocolo de manejo. Enferm Clín. 2010:20(1);3-9.

  17. Velázquez-Mendoza S, Gómez-Alonso C, Cuamatzi- Peña MT, Izquierdo-Puente MI. Conocimiento y criterios de enfermería para evitar flebitis en neonatos con catéter venoso periférico. Rev Enferm Inst Mex Seguro Soc. 2009;17(3):143-7.

  18. Coria-Lorenzo JJ, Gallardo-del Valle D, Saavedra- Barrios MA, Castilla-Serna L, Guevara-Leonel R, De la Luz-Rosas G. Riesgo de bacteremia por soluciones parenterales. Estudio prospectivo en un servicio de Infectología. Rev Mex Pediatr. 2003;70(1);5-9.

  19. Webster J, Osborne S, Rickard CM, New K. Clinically- indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2013;30:4.

  20. Denisia-de Brito C, Ribeiro-de Paula Lima ED. Dispositivo intravascular periférico curto mais seguro para infusão de quimioterápicos antineoplásticos vesicantes: o que a literatura diz. Revista Mineira de Enfermagem[Internet]. 2012;16:2 Disponible en: http://www.reme.org.br/artigo/detalhes/529

  21. Ferrer-Espin A, Macías-Garrido E, Meza-Cardona J, Cabrera-Jardines R, Rodriguez-Weber F, Díaz- Greene, et al. Infecciones relacionadas con catéteres venosos: incidencia y otros factores. Med Int Mex. 2008; 24(2):112-9.

  22. González-Velázquez J, González-Cejudo MN, Pardo- Morales RV. Infecciones nosocomiales relacionadas a catéter central. Arch Inv Mat Inf. 2012; IV (1):33-8.

  23. Ainsworth S, Clerihew L, McGuire W. Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates. Cochrane Database Syst Rev2007; 3: CD004219. DOI:10.1002/14651858.CD004219.pub3.

  24. Barria RM, Santander G. Acceso vascular periférico en neonatos de cuidado intensivo: experiencia de un hospital público. Ciencia y enfermería[Internet]. 2006;XII(2):35-44.




2020     |     www.medigraphic.com